Optimism turns to concern as Cann Group battles financial uncertainty by Steve Jones March 7, 2024March 7, 2024 With its shares suspended from the ASX amid auditor concern over its ability to keep trading, […]
Cann Group shares suspended as auditor reports ‘insufficient evidence’ of future funding by Steve Jones March 1, 2024March 1, 2024
Australian cannabis cultivators call for industry support by Martin Lane February 22, 2024February 22, 2024
Cann Group inks deal to raise A$2m with more funds on the horizon by Steve Jones November 21, 2023November 23, 2023
Cann Group doubles revenue but ASX again seeks reassurance over finances by Steve Jones October 31, 2023October 31, 2023
Company news: Vantage Hemp; Neurotech International; MediPharm Labs/Beacon Medical; Cann Group by Martin Lane September 28, 2023September 28, 2023
Judge us on the future, not the past, says Cann Group CEO amid calls to view annual report ‘in context’ by Steve Jones August 30, 2023August 31, 2023
Cann Group to target institutional investors after capital raise falls short by Steve Jones July 28, 2023July 28, 2023
Cann Group aims for profitability ‘within two years’ as revenue doubles in FY23 by Steve Jones July 5, 2023July 6, 2023
Cann Group in multimillion-dollar cap raise to fund Mildura production growth by Steve Jones June 15, 2023June 15, 2023